US Patent Issued to THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH on June 3 for "Macrophage-based therapy" (British Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,476, issued on June 3, was assigned to THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (Great Britain).

"Macrophage-based therapy" was invented by Stuart Forbes (Edinburgh, Great Britain), John Campbell (Edinburgh, Great Britain), Neil W. A. McGowan (Edinburgh, Great Britain) and Alasdair R. Fraser (Edinburgh, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relate to autologous isolated unpolarized human macrophages for use in the treatment of liver disease and macrophages for use in a method of treating fibrosis in a human in need thereof."

The patent was filed on March 15, 2019, under Application No. 16/980,7...